Hypoglycemia-induced myocardial infarction: an unusual adverse effect of sulfonylureas.
Hypoglycemia is a significant problem of sulfonylureas treated diabetes. Although attention has focused on its neurologic consequence, the possibility of cardiovascular side effects should also be considered. A 77-year-old man presented with hypoglycemia-induced myocardial infarction with sulfonylureas therapy. We wish to report this unusual adverse effect of sulfonylureas and provide some reference for the clinicians who treat similar cases.
Chang
Jen-Hung
JH
Tseng
Chin-Feng
CF
Wang
Jen-Yu
JY
D000368:Aged; D017023:Coronary Angiography; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000150:complications*; D008297:Male; D009203:Myocardial Infarction / Q000000981:diagnostic imaging / Q000209:etiology* / Q000503:physiopathology; D011379:Prognosis; D018570:Risk Assessment; D013453:Sulfonylurea Compounds / Q000009:adverse effects* / Q000627:therapeutic use
D013453:Sulfonylurea Compounds